logo
AI Icon𝛼SK or Search
ENTITY

Starton Holdings (STA US)

2
Analysis
Health Care • United States
Starton Holdings, Inc. is a clinical-stage biotechnology company that uses its proprietary continuous delivery technology platform to improve standard-of-care cancer therapies. The company is conducting an initial public offering to fund the development of its lead product candidates, STAR-LLD, which are continuous delivery systems of lenalidomide for various hematologic malignancies.
more
bearish•Starton Holdings
•17 Jul 2026 12:00

Starton Holdings (STA US): Synthetic Expert Call Transcript (17 Jul 2026)

Commercial Obsolescence of SC Platform: The continuous subcutaneous delivery system (STAR-LLD-SC) via ambulatory pump is functionally dead as a...

Logo
Share
bullish•Starton Holdings
•17 Jul 2026 10:15

IPO Databook: Starton Holdings (STA US) - Jul 2026

Starton Holdings, a clinical-stage biotechnology company, uses its proprietary continuous delivery platform to improve cancer therapies, funding...

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x